Literature DB >> 28938488

Ovarian Aging in Women With BRCA Germline Mutations.

Wayne Lin1, Shiny Titus2, Fred Moy3, Elizabeth S Ginsburg1, Kutluk Oktay2.   

Abstract

Context: Recent clinical and laboratory studies suggested that women with BRCA mutations have lower ovarian reserve and their primordial follicle oocytes may be more prone to DNA damage; however, direct proof is lacking. Objective: To determine whether women with germline BRCA mutations have reduced primordial follicle reserve and increased oocyte DNA damage. Design: A comparative laboratory study of ovarian tissue obtained from unaffected BRCA mutation carriers (BMCs) vs age-matched organ donor cadavers. Setting: Two academic centers. Patients or Other Participants: Of the 230 ovarian specimens from BMCs, 18 met the study inclusion criteria. Healthy ovaries from 12 organ donor cadavers served as controls. Intervention: Histology and immunohistochemical analysis on paraffin-embedded ovarian sections. Main Outcome Measure(s): Primordial follicle density and the percentage of DNA double-strand break (DSB)-positive primordial follicle oocytes.
Results: Ovaries from BMCs had significantly lower primordial follicle densities than those of controls (11.2 ± 2.0 vs 44.2 ± 6.2 follicles/mm3; P = 0.0002). BRCA mutations were associated with increased DNA DSBs in primordial follicle oocytes (62% ± 5.2% vs 36% ± 3.4%; P = 0.0005). In subgroup analyses, both BRCA1 and BRCA2 mutations were associated with lower primordial follicle density (P = 0.0001 and 0.0030, respectively), and BRCA1 mutations were associated with higher DNA DSBs (P = 0.0003) than controls. The rates of follicle decline (R2 = 0.74; P = 0.0001) and DNA DSB accumulation (R2 = 0.70; P = 0.0001) appeared to be accelerated, particularly in primordial follicle oocytes of BMCs over age 30 years. Conclusions: We provide direct evidence of diminished ovarian reserve as well as accelerated primordial follicle loss and oocyte DNA damage in women with BRCA mutations. These findings may further our understanding of ovarian aging, and be useful when counseling BMCs.
Copyright © 2017 Endocrine Society

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28938488      PMCID: PMC5630253          DOI: 10.1210/jc.2017-00765

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  31 in total

1.  Factoring in complexity and oocyte memory--can transformations and cyperpathology distort reality?

Authors:  M J Faddy; R G Gosden; K Oktay; J F Nelson
Journal:  Fertil Steril       Date:  1999-06       Impact factor: 7.329

2.  High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status.

Authors:  Renato Fanchin; Joëlle Taieb; Daniel H Mendèz Lozano; Béatrice Ducot; René Frydman; Jean Bouyer
Journal:  Hum Reprod       Date:  2005-01-07       Impact factor: 6.918

Review 3.  Ovarian aging: mechanisms and clinical consequences.

Authors:  F J Broekmans; M R Soules; B C Fauser
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

4.  The relationship between anti-Müllerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies.

Authors:  M Dólleman; M J Faddy; J van Disseldorp; Y T van der Schouw; C M Messow; B Leader; P H M Peeters; A McConnachie; S M Nelson; F J M Broekmans
Journal:  J Clin Endocrinol Metab       Date:  2013-03-18       Impact factor: 5.958

5.  Dynamics of follicular growth in the human: a model from preliminary results.

Authors:  A Gougeon
Journal:  Hum Reprod       Date:  1986-02       Impact factor: 6.918

Review 6.  Smoking and reproduction: gene damage to human gametes and embryos.

Authors:  M T Zenzes
Journal:  Hum Reprod Update       Date:  2000 Mar-Apr       Impact factor: 15.610

7.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

Review 8.  Cancer susceptibility and the functions of BRCA1 and BRCA2.

Authors:  Ashok R Venkitaraman
Journal:  Cell       Date:  2002-01-25       Impact factor: 41.582

Review 9.  Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called "hyperthecosis".

Authors:  P E Hughesdon
Journal:  Obstet Gynecol Surv       Date:  1982-02       Impact factor: 2.347

10.  Proliferating cell nuclear antigen marks the initiation of follicular growth in the rat.

Authors:  K Oktay; R S Schenken; J F Nelson
Journal:  Biol Reprod       Date:  1995-08       Impact factor: 4.285

View more
  26 in total

1.  Easing US restrictions on mitochondrial replacement therapy would protect research interests but grease the slippery slope.

Authors:  David L Keefe
Journal:  J Assist Reprod Genet       Date:  2019-08-28       Impact factor: 3.412

Review 2.  Emerging roles for noncoding RNAs in female sex steroids and reproductive disease.

Authors:  Runju Zhang; Victoria Wesevich; Zhaojuan Chen; Dan Zhang; Amanda N Kallen
Journal:  Mol Cell Endocrinol       Date:  2020-07-12       Impact factor: 4.102

3.  Impairment of Pol β-related DNA base-excision repair leads to ovarian aging in mice.

Authors:  Ke Hua; Liping Wang; Junhua Sun; Nanhai Zhou; Yilan Zhang; Feng Ji; Li Jing; Yang Yang; Wen Xia; Zhigang Hu; Feiyan Pan; Xi Chen; Bing Yao; Zhigang Guo
Journal:  Aging (Albany NY)       Date:  2020-11-20       Impact factor: 5.682

4.  Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency.

Authors:  Kutluk H Oktay; Giuliano Bedoschi; Shari B Goldfarb; Enes Taylan; Shiny Titus; Glenn E Palomaki; Tessa Cigler; Mark Robson; Maura N Dickler
Journal:  Fertil Steril       Date:  2020-04-22       Impact factor: 7.329

Review 5.  BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging.

Authors:  Volkan Turan; Kutluk Oktay
Journal:  Hum Reprod Update       Date:  2020-01-01       Impact factor: 15.610

6.  Navigating the body of literature assessing BRCA1/2 mutations and markers of ovarian function: a systematic review and meta-analysis.

Authors:  Christina N Cordeiro Mitchell; Bailey McGuinness; Eliana Fine; William G Kearns; Mindy S Christianson; James Segars; Lisa M Pastore
Journal:  J Assist Reprod Genet       Date:  2020-03-24       Impact factor: 3.412

7.  Novel variants in women with premature ovarian function decline identified via whole-exome sequencing.

Authors:  Ruiyi Tang; Qi Yu
Journal:  J Assist Reprod Genet       Date:  2020-08-13       Impact factor: 3.412

Review 8.  Fertility preservation for genetic diseases leading to premature ovarian insufficiency (POI).

Authors:  Antonio La Marca; Elisa Mastellari
Journal:  J Assist Reprod Genet       Date:  2021-01-25       Impact factor: 3.412

9.  Integrated stress response control of granulosa cell translation and proliferation during normal ovarian follicle development.

Authors:  Evelyn Llerena Cari; Synneva Hagen-Lillevik; Asma Giornazi; Miriam Post; Anton A Komar; Leslie Appiah; Benjamin Bitler; Alex J Polotsky; Nanette Santoro; Jeffrey Kieft; Kent Lai; Joshua Johnson
Journal:  Mol Hum Reprod       Date:  2021-08-07       Impact factor: 4.025

Review 10.  Meiosis interrupted: the genetics of female infertility via meiotic failure.

Authors:  Leelabati Biswas; Katarzyna Tyc; Warif El Yakoubi; Katie Morgan; Jinchuan Xing; Karen Schindler
Journal:  Reproduction       Date:  2021-02       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.